Live
- Satya Kumar flays YSRCP govt for ruining new med colleges
- AP High Court to hear RGVs anticipatory bail plea in social media remarks case
- ICC Champions Trophy: PCB appoints Chief Operating Officer; reiterates stand to host Champions Trophy entirely in Pakistan
- Probe initiated after food poisoning incident
- BGT 2024-25: Nitish Kumar Reddy, Harshit Rana make India Test debuts in first Border-Gavaskar Trophy in Perth
- 100 students fall sick after consuming contaminated food
- TCS will commence ops in Visakha in 3 months: Lokesh
- Pawan, 2 other ministers rule out VSP privatisation
- HC Bench In Kurnool: House passes unanimous resolution
- Low Pressure Area Likely in Southeast Bay of Bengal, Heavy Rains Forecasted for AP
Sputnik Light vax: Hetero arm gets CDSCO approval
Sputnik Light vax: Hetero arm gets CDSCO approval
Drug firm Hetero on Monday said its biologics arm has received approval from the Central Drugs Standard Control Organisation (CDSCO) to manufacture and sell Sputnik Light for restricted emergency use in India.
Hyderabad: Drug firm Hetero on Monday said its biologics arm has received approval from the Central Drugs Standard Control Organisation (CDSCO) to manufacture and sell Sputnik Light for restricted emergency use in India.
Hetero is the first biopharmaceutical company in India to receive Manufacturing and Marketing (M&M) approval for the product manufactured locally for the prevention of Covid-19 in adults aged over 18 years, administered in a single dose of 0.5 ml, the company said in a statement.
All other currently approved vaccines in India require two doses of administration, it added. Sputnik Light is the first component (recombinant human adenovirus serotype number 26 (rAd26)) of Sputnik V – the world's first registered vaccine against Covid-19.
In February 2022, the Drugs Controller General of India (DCGI) granted emergency use permission to single-dose Sputnik Light Covid-19 vaccine in India.
